New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
OZEMvsETF 2ETF Comparison
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with OZEM, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
OZEM performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | OZEM ETF 2 | -10.89%– | -7.23%– | -7.16%– | +31.31%– | n/a– | n/a– |
| Flows | OZEM ETF 2 | +$3M– | +$16M– | +$16M– | +$10M– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | OZEM ETF 2 | +22.47%– | +25.49%– | n/a– | n/a– |
| Max drawdown | OZEM ETF 2 | -14.23%– | -15.51%– | n/a– | n/a– |
| Max drawdown duration | OZEM ETF 2 | 45d– | 42d– | n/a– | n/a– |
Trading data
OZEM | ETF 2 | |
Last sale 3/12/2026 at 1:30 PM | $31.59 | – |
| Previous close 03/12/2026 | $32.28 | – |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
OZEM | ETF 2 | |
|---|---|---|
| Last price | $31.59 | – |
| 1D performance | -2.15% | – |
| AuM | $55.72 M | – |
| E/R | 0.59% | – |
Characteristics
OZEM | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Roundhill Investments | – |
| Benchmark | - | – |
| N° of holdings | 20 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 21, 2024 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
OZEM
USA
63.33%
Cayman Islands
9%
Other
27.67%
ETF 2
Sectors
OZEM
Health Care
65.61%
Other
34.39%
ETF 2
Advertisement
Diversification
OZEM
Total weight of top 15 holdings out of 15
84.13%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
OZEM
US6701002056
22.10%
LILLY
14.43%
US86366E1064
4.93%
ROCHE
4.21%
CHUGAI PHARMACEUTICAL
3.92%
PFIZER
3.92%
ZEALAND PHARMA
3.84%
HANMI PHARM
3.77%
PHARMA INC
3.72%
VIKING THERPTC/D
3.60%
AMGEN-T
3.54%
INNOVENT BIOLOGICS INC
3.29%
SHANGHAI FOSUN PHARMACEUTICAL (GRP)I
3.20%
US0463531089
3.06%
REGENERON PHARMACEUTICALS
2.60%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about OZEM
Advertisement
Advertisement
Advertisement
The Active Trader Report
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
